GRI Bio Inc. (GRI) — Financial Flexibility Index

Latest as of December 2025: -1.12x

GRI Bio Inc. (GRI) has a Financial Flexibility Index of -1.12x as of December 2025. Free cash flow of $-2.97 Million (operating CF $-2.97 Million minus capex $3.00K) represents -1% of total liabilities ($2.66 Million). Also explore how fast is GRI Bio Inc. growing its equity to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-1.12x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-2.97 Million
Operating CF − Capex

Total Liabilities

$2.66 Million
USD

Capital Expenditures

$3.00K
USD

GRI Bio Inc. Financial Flexibility Index (2018–2025)

Historical Financial Flexibility Index trend for GRI Bio Inc. across 8 annual periods. Check GRI strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for GRI Bio Inc. (2018–2025)

Year-by-year free cash flow to debt coverage for GRI Bio Inc.. For the full company profile including market capitalisation, see GRI Bio Inc. market capitalisation.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2025 -3.83x $-10.18 Million $-10.19 Million $2.66 Million ▲ +24.1%
2024 -5.04x $-8.61 Million $-8.61 Million $1.71 Million ▼ -51.5%
2023 -3.33x $-8.98 Million $-8.99 Million $2.70 Million ▼ -518.1%
2022 -0.54x $-1.08 Million $-1.08 Million $2.01 Million ▼ -214.4%
2021 -0.17x $-847.00K $-847.00K $4.94 Million ▲ +88.9%
2020 -1.54x $-3.70 Million $-3.71 Million $2.41 Million ▲ +43.4%
2019 -2.72x $-2.88 Million $-2.88 Million $1.06 Million ▲ +44.2%
2018 -4.87x $-2.37 Million $-2.37 Million $486.29K
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities